Primary cutaneous follicle center lymphoma with diffuse CD30 expression: A report of 4 cases of a rare variant

This rare variant of CD30+ PCFCL needs be distinguished from CD30+ aggressive B-cell lymphomas. CD30 in this variant of CBCLs may serve as a therapeutic target for anti-CD30 antibody-based strategies.